A selective IDO1 inhibitor (IC50s = 67 and 19 nM for human IDO in enzymatic activity and HeLa cell assays, respectively); decreases kynurenine levels in plasma and dose-dependently reduces the growth of GM-CSF-secreting B16 tumor xenografts in mice at 25-75 mg/kg